Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy

BMC Public Health

Table 2 Proportion of prisons adherent to national and WHO guidelines for each sub-score composing the global adherence score (ANRS PRI²DE) (N = 103 prisons)

	France % [95%CI]	WHO % [95%CI]
Bleach: access and information	14 [7-20]	6 [1-10]
Condom & Lubricants: access and information	9 [3-14]	12 [5-18]
Opioid Substitution Treatment	27 [18-36]	27 [18-36]
HIV-HCV-HBV Screening	64 [55-74]	0%*
HBV vaccination	83 [75-90]	NA
Information Education Communication	66 [57-75]	0%*
Post-Exposition Prophylaxis	23 [14-31]	23 [14-31]
Hair cutting measures	33 [24-42]	NA
NSP	NA	0%**

* A condition of simultaneous availability of condoms and NSP (not authorized in French prisons) is required in WHO guidelines
** NSP are not authorized in French prisons but are available in the community. NA = Not Available

ISSN: 1471-2458